| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 0510 |
|
419,252 |
320,453 |
$7.21M |
| 90999 |
Unlisted dialysis procedure, inpatient or outpatient |
54,573 |
4,545 |
$7.10M |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
337,632 |
261,352 |
$7.00M |
| 0450 |
Emergency room services |
135,213 |
117,965 |
$6.91M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
97,730 |
83,492 |
$4.97M |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
10,893 |
10,581 |
$3.74M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
17,289 |
16,425 |
$2.99M |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
3,542 |
3,383 |
$2.90M |
| 99070 |
|
220,800 |
102,489 |
$2.55M |
| 70450 |
Computed tomography, head or brain; without contrast material |
16,917 |
16,095 |
$2.46M |
| Z7502 |
|
55,410 |
54,820 |
$2.08M |
| J9035 |
Injection, bevacizumab, 10 mg |
1,737 |
1,304 |
$2.07M |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
21,246 |
20,840 |
$1.88M |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
12,344 |
12,079 |
$1.84M |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
211,969 |
189,558 |
$1.82M |
| 80053 |
Comprehensive metabolic panel |
179,298 |
163,693 |
$1.77M |
| Z7500 |
|
51,452 |
46,675 |
$1.75M |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
7,325 |
7,027 |
$1.67M |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
20,413 |
19,200 |
$1.59M |
| J9299 |
Injection, nivolumab, 1 mg |
353 |
115 |
$1.51M |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
54,857 |
49,491 |
$1.48M |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
45,733 |
44,184 |
$1.44M |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
45,714 |
44,160 |
$1.43M |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
38,104 |
35,530 |
$1.40M |
| 93976 |
|
7,119 |
6,891 |
$1.36M |
| 84443 |
Thyroid stimulating hormone (TSH) |
105,294 |
101,240 |
$1.36M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
62,037 |
13,482 |
$1.33M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
22,389 |
19,177 |
$1.29M |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
10,875 |
10,585 |
$1.25M |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
1,505 |
1,462 |
$1.24M |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
52,860 |
48,057 |
$1.20M |
| 90750 |
|
7,184 |
6,885 |
$1.18M |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
2,332 |
2,289 |
$1.17M |
| 0360 |
|
10,866 |
5,544 |
$1.14M |
| 80074 |
|
32,279 |
31,267 |
$1.10M |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
20,659 |
13,409 |
$1.03M |
| 80048 |
Basic metabolic panel (calcium, ionized) |
86,115 |
76,563 |
$1.03M |
| 99499 |
|
25,086 |
19,967 |
$896K |
| J9271 |
Injection, pembrolizumab, 1 mg |
242 |
94 |
$871K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
125,131 |
120,448 |
$829K |
| 0762 |
|
9,111 |
4,249 |
$810K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
16,655 |
16,055 |
$776K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
13,097 |
12,466 |
$770K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
3,747 |
3,664 |
$762K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
62,308 |
59,904 |
$761K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
1,936 |
1,803 |
$716K |
| 80061 |
Lipid panel |
99,959 |
96,775 |
$713K |
| J3490 |
Unclassified drugs |
90,862 |
45,938 |
$709K |
| Q5107 |
Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg |
588 |
236 |
$685K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
2,967 |
2,081 |
$681K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
1,485 |
1,450 |
$656K |
| 86803 |
|
30,674 |
29,557 |
$651K |
| 71046 |
Radiologic examination, chest; 2 views |
35,146 |
33,641 |
$639K |
| 83721 |
|
99,939 |
96,616 |
$634K |
| 87581 |
|
10,876 |
10,588 |
$629K |
| 87486 |
|
10,866 |
10,580 |
$628K |
| 84484 |
|
34,497 |
29,957 |
$623K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
12,107 |
11,664 |
$620K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
10,802 |
10,543 |
$612K |
| 0720 |
|
13,956 |
8,740 |
$605K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
27,275 |
25,747 |
$595K |
| 99221 |
|
4,029 |
3,796 |
$594K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
6,266 |
6,101 |
$587K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
47,429 |
46,359 |
$558K |
| 90715 |
|
16,446 |
15,957 |
$515K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
7,790 |
6,489 |
$507K |
| 71250 |
|
2,694 |
2,618 |
$505K |
| 90677 |
|
2,894 |
2,884 |
$496K |
| 86780 |
|
66,149 |
62,379 |
$480K |
| T1014 |
Telehealth transmission, per minute, professional services bill separately |
156,456 |
142,071 |
$480K |
| 59025 |
Fetal non-stress test |
26,173 |
13,583 |
$470K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
3,285 |
3,112 |
$452K |
| 73221 |
|
1,250 |
1,180 |
$443K |
| 72141 |
|
869 |
851 |
$442K |
| 80076 |
|
35,552 |
33,315 |
$418K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
11,284 |
10,227 |
$407K |
| 99401 |
|
5,001 |
4,934 |
$378K |
| 90651 |
|
3,233 |
3,179 |
$376K |
| Q5105 |
Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for esrd on dialysis), 100 units |
12,217 |
1,731 |
$376K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
184,603 |
172,054 |
$376K |
| 70486 |
|
2,213 |
2,159 |
$366K |
| 99402 |
|
5,286 |
5,018 |
$355K |
| 83690 |
|
30,389 |
28,354 |
$341K |
| 81001 |
|
82,286 |
76,236 |
$338K |
| 93970 |
|
2,213 |
2,137 |
$334K |
| 85027 |
|
55,299 |
51,056 |
$334K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
7,404 |
6,670 |
$333K |
| 0710 |
|
12,558 |
11,728 |
$331K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
3,839 |
3,634 |
$326K |
| 97750 |
|
6,884 |
6,390 |
$316K |
| 72132 |
|
2,256 |
2,171 |
$312K |
| 70498 |
|
2,007 |
1,969 |
$301K |
| 82948 |
|
56,372 |
43,704 |
$298K |
| 93351 |
|
2,729 |
2,655 |
$298K |
| V2632 |
Posterior chamber intraocular lens |
1,161 |
1,122 |
$297K |
| 82805 |
|
5,674 |
5,329 |
$291K |
| 72129 |
|
2,168 |
2,086 |
$290K |
| 72126 |
|
2,077 |
2,001 |
$283K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
36,868 |
24,975 |
$282K |
| 81025 |
|
48,149 |
45,312 |
$281K |
| 76801 |
|
5,660 |
4,591 |
$272K |
| 70491 |
|
1,293 |
1,241 |
$265K |
| 90736 |
|
1,294 |
1,271 |
$265K |
| 87040 |
|
8,236 |
7,690 |
$263K |
| 93971 |
|
2,860 |
2,751 |
$262K |
| 83605 |
|
12,807 |
11,682 |
$258K |
| 90732 |
|
2,671 |
2,599 |
$255K |
| 73630 |
|
10,866 |
10,263 |
$252K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
8,878 |
5,073 |
$246K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
4,611 |
4,435 |
$239K |
| 73130 |
|
9,738 |
8,980 |
$239K |
| 76642 |
|
3,867 |
3,668 |
$239K |
| G0378 |
Hospital observation service, per hour |
4,299 |
3,907 |
$237K |
| Z9725 |
|
7,899 |
7,662 |
$235K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
5,278 |
4,837 |
$232K |
| 76770 |
|
3,604 |
3,496 |
$228K |
| 73610 |
|
9,617 |
8,982 |
$227K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
13,611 |
13,060 |
$226K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
8,326 |
7,943 |
$225K |
| 73030 |
|
9,041 |
8,596 |
$223K |
| 83735 |
|
29,331 |
24,982 |
$221K |
| 83970 |
|
6,327 |
6,008 |
$218K |
| 90670 |
|
3,515 |
3,450 |
$218K |
| 83880 |
|
9,346 |
8,890 |
$215K |
| 82803 |
|
6,828 |
6,346 |
$214K |
| 82607 |
|
19,404 |
18,892 |
$213K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
3,697 |
3,370 |
$212K |
| 71045 |
Radiologic examination, chest; single view |
21,426 |
20,360 |
$208K |
| 73110 |
|
8,936 |
8,030 |
$208K |
| 72100 |
|
7,990 |
7,564 |
$207K |
| 76830 |
Ultrasound, transvaginal |
3,572 |
3,482 |
$199K |
| Z7610 |
|
30,272 |
19,883 |
$198K |
| 85730 |
|
26,828 |
24,890 |
$197K |
| 84439 |
|
24,360 |
23,475 |
$195K |
| 82728 |
|
18,950 |
18,259 |
$194K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
2,214 |
2,127 |
$193K |
| 85610 |
|
46,767 |
39,626 |
$191K |
| 70496 |
|
1,104 |
1,078 |
$191K |
| 77065 |
Tomosynthesis, mammo |
2,285 |
2,234 |
$189K |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
883 |
666 |
$182K |
| 73564 |
|
6,582 |
6,344 |
$178K |
| 97139 |
|
8,131 |
2,018 |
$172K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
27,199 |
25,481 |
$171K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
2,913 |
2,837 |
$164K |
| 76813 |
|
2,331 |
2,203 |
$164K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
3,504 |
2,915 |
$164K |
| 87522 |
Neg quan hep c or qual rna |
3,674 |
3,555 |
$164K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
37,715 |
36,255 |
$152K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
5,396 |
4,217 |
$151K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
615 |
603 |
$149K |
| L2116 |
Ankle foot orthosis, fracture orthosis, tibial fracture orthosis, rigid, prefabricated, includes fitting and adjustment |
269 |
263 |
$148K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
1,153 |
1,111 |
$146K |
| S3620 |
Newborn metabolic screening panel, includes test kit, postage and the laboratory tests specified by the state for inclusion in this panel (e.g., galactose; hemoglobin, electrophoresis; hydroxyprogesterone, 17-d; phenylalanine (pku); and thyroxine, total) |
1,100 |
938 |
$146K |
| 84100 |
|
31,439 |
26,483 |
$145K |
| 90688 |
|
8,001 |
7,820 |
$143K |
| 84702 |
|
10,974 |
9,329 |
$143K |
| 86941 |
|
8,929 |
8,183 |
$143K |
| 76536 |
|
2,957 |
2,892 |
$141K |
| 90746 |
|
2,256 |
2,195 |
$140K |
| 86850 |
|
16,432 |
15,167 |
$137K |
| L1980 |
Ankle foot orthosis, single upright free plantar dorsiflexion, solid stirrup, calf band/cuff (single bar 'bk' orthosis), custom fabricated |
530 |
507 |
$132K |
| 86480 |
|
5,359 |
5,225 |
$132K |
| 93271 |
|
1,845 |
1,810 |
$129K |
| 90678 |
|
717 |
713 |
$127K |
| 77412 |
|
2,409 |
247 |
$125K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
4,956 |
4,497 |
$124K |
| 82570 |
|
38,549 |
36,762 |
$122K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,293 |
3,986 |
$122K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
1,456 |
1,365 |
$120K |
| 96417 |
|
3,505 |
2,225 |
$120K |
| 72110 |
|
2,786 |
2,747 |
$119K |
| 94060 |
|
1,958 |
1,900 |
$115K |
| 76870 |
|
2,114 |
2,047 |
$114K |
| J0897 |
Injection, denosumab, 1 mg |
109 |
61 |
$113K |
| 73590 |
|
5,882 |
5,568 |
$112K |
| 74178 |
|
565 |
543 |
$112K |
| 86901 |
|
19,358 |
17,270 |
$110K |
| 81329 |
|
1,050 |
1,037 |
$109K |
| 85379 |
|
7,379 |
6,788 |
$108K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
1,801 |
1,716 |
$107K |
| 81220 |
CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants |
1,296 |
1,273 |
$105K |
| 72131 |
|
627 |
622 |
$103K |
| Q4081 |
Injection, epoetin alfa, 100 units (for esrd on dialysis) |
12,144 |
1,449 |
$103K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
528 |
501 |
$102K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
2,264 |
2,184 |
$102K |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
4,490 |
4,345 |
$102K |
| 77336 |
|
2,527 |
992 |
$102K |
| 96416 |
|
2,244 |
1,219 |
$99K |
| 82550 |
|
9,489 |
8,001 |
$99K |
| 67028 |
Intravitreal injection of a pharmacologic agent |
2,330 |
2,009 |
$98K |
| 0511 |
|
5,066 |
4,484 |
$98K |
| J7307 |
Etonogestrel (contraceptive) implant system, including implant and supplies |
104 |
100 |
$97K |
| 93017 |
|
1,929 |
1,860 |
$95K |
| 95913 |
|
426 |
405 |
$95K |
| 73700 |
|
460 |
432 |
$95K |
| 97799 |
|
4,474 |
1,840 |
$93K |
| 95911 |
|
1,141 |
1,128 |
$92K |
| 73502 |
|
3,638 |
3,552 |
$91K |
| 81003 |
|
35,641 |
34,004 |
$91K |
| J0640 |
Injection, leucovorin calcium, per 50 mg |
1,894 |
1,002 |
$90K |
| 73080 |
|
3,776 |
3,490 |
$88K |
| 73090 |
|
4,762 |
4,347 |
$88K |
| 83550 |
|
15,151 |
14,659 |
$88K |
| J1756 |
Injection, iron sucrose, 1 mg |
8,180 |
2,103 |
$87K |
| G0109 |
Diabetes outpatient self-management training services, group session (2 or more), per 30 minutes |
2,181 |
1,336 |
$87K |
| 73560 |
|
4,186 |
3,994 |
$86K |
| 72040 |
|
3,709 |
3,610 |
$86K |
| 0760 |
|
5,882 |
4,949 |
$86K |
| 86900 |
|
21,042 |
18,689 |
$86K |
| 87631 |
|
1,576 |
1,542 |
$85K |
| 96415 |
|
3,188 |
2,032 |
$85K |
| 97763 |
|
2,641 |
1,395 |
$85K |
| 82746 |
|
7,850 |
7,657 |
$83K |
| 81002 |
|
31,967 |
24,881 |
$82K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
2,591 |
1,993 |
$82K |
| 77066 |
Tomosynthesis, mammo |
800 |
781 |
$82K |
| 83540 |
|
16,728 |
16,143 |
$80K |
| 97039 |
|
3,582 |
1,817 |
$80K |
| 87186 |
|
7,013 |
6,638 |
$79K |
| 66982 |
|
458 |
432 |
$78K |
| 73562 |
|
3,226 |
3,098 |
$78K |
| 93308 |
|
1,175 |
1,166 |
$77K |
| 99218 |
|
553 |
529 |
$76K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
2,098 |
2,021 |
$76K |
| 88142 |
|
17,064 |
16,782 |
$75K |
| 84153 |
|
5,858 |
5,577 |
$75K |
| 84132 |
|
15,155 |
10,031 |
$75K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
1,936 |
1,869 |
$72K |
| 92083 |
|
5,059 |
4,945 |
$69K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
983 |
949 |
$69K |
| L3808 |
Wrist hand finger orthosis, rigid without joints, may include soft interface material; straps, custom fabricated, includes fitting and adjustment |
454 |
440 |
$66K |
| 93270 |
|
1,812 |
1,776 |
$65K |
| 93226 |
|
1,331 |
1,290 |
$65K |
| 71271 |
|
899 |
889 |
$64K |
| 82043 |
|
16,689 |
15,897 |
$63K |
| 86762 |
|
5,887 |
5,599 |
$62K |
| 77387 |
|
313 |
41 |
$61K |
| 92133 |
|
5,370 |
5,256 |
$61K |
| 87340 |
|
7,382 |
7,033 |
$60K |
| 86328 |
|
1,540 |
1,402 |
$60K |
| 82274 |
|
13,168 |
12,862 |
$60K |
| 88307 |
|
579 |
562 |
$59K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
731 |
691 |
$59K |
| 86920 |
|
738 |
639 |
$59K |
| 76000 |
|
3,129 |
2,877 |
$59K |
| 92235 |
|
768 |
745 |
$58K |
| 77300 |
|
139 |
132 |
$58K |
| 73620 |
|
3,059 |
2,949 |
$56K |
| 94729 |
|
1,442 |
1,409 |
$56K |
| 84295 |
|
8,788 |
8,230 |
$55K |
| 73120 |
|
2,823 |
2,689 |
$55K |
| 82435 |
|
8,664 |
8,111 |
$55K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
33,356 |
30,770 |
$54K |
| 90585 |
|
783 |
756 |
$54K |
| 20610 |
|
2,204 |
1,985 |
$54K |
| 96367 |
|
1,529 |
1,188 |
$53K |
| 73552 |
|
2,505 |
2,404 |
$51K |
| 73600 |
|
2,578 |
2,429 |
$51K |
| J3489 |
Injection, zoledronic acid, 1 mg |
1,543 |
1,428 |
$50K |
| 84146 |
|
3,196 |
3,122 |
$50K |
| 77080 |
|
1,812 |
1,765 |
$49K |
| 93225 |
|
1,330 |
1,289 |
$48K |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
2,456 |
2,384 |
$48K |
| 86003 |
|
2,514 |
2,282 |
$48K |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
1,792 |
1,727 |
$48K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
347 |
323 |
$48K |
| 73060 |
|
2,553 |
2,338 |
$47K |
| 82378 |
|
2,595 |
2,230 |
$46K |
| 85018 |
|
19,735 |
18,134 |
$46K |
| 0515 |
|
15,953 |
14,893 |
$46K |
| 83001 |
|
2,970 |
2,915 |
$45K |
| 86141 |
|
6,429 |
6,145 |
$45K |
| 90662 |
|
1,857 |
1,819 |
$44K |
| 94726 |
|
1,061 |
1,034 |
$44K |
| 73565 |
|
2,826 |
2,764 |
$44K |
| 90671 |
|
935 |
929 |
$44K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
266 |
263 |
$44K |
| 74174 |
|
137 |
133 |
$43K |
| 90686 |
|
3,182 |
3,124 |
$42K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
867 |
816 |
$42K |
| 90707 |
|
1,619 |
1,593 |
$42K |
| 73070 |
|
2,144 |
2,012 |
$42K |
| L3260 |
Surgical boot/shoe, each |
493 |
486 |
$41K |
| 86038 |
|
5,244 |
5,043 |
$41K |
| 73100 |
|
2,344 |
2,179 |
$40K |
| 83002 |
|
2,612 |
2,561 |
$40K |
| 74018 |
|
2,468 |
2,377 |
$40K |
| 70487 |
|
225 |
222 |
$40K |
| 72072 |
|
1,296 |
1,276 |
$39K |
| 83615 |
|
6,713 |
6,096 |
$39K |
| 36415 |
Collection of venous blood by venipuncture |
13,387 |
9,670 |
$38K |
| J1644 |
Injection, heparin sodium, per 1000 units |
41,999 |
5,108 |
$38K |
| 72170 |
|
2,080 |
2,023 |
$38K |
| 93880 |
|
301 |
294 |
$37K |
| 72050 |
|
994 |
966 |
$37K |
| 87077 |
|
6,886 |
6,576 |
$37K |
| 75574 |
|
198 |
193 |
$37K |
| 86923 |
|
409 |
337 |
$36K |
| 76604 |
|
840 |
836 |
$36K |
| 90710 |
|
637 |
635 |
$35K |
| Q3014 |
Telehealth originating site facility fee |
3,690 |
3,550 |
$35K |
| 85384 |
|
3,303 |
2,844 |
$35K |
| 97165 |
|
792 |
723 |
$34K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
1,272 |
1,242 |
$34K |
| 82552 |
|
1,387 |
1,149 |
$34K |
| 86140 |
|
7,265 |
6,804 |
$34K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
344 |
331 |
$34K |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
3,528 |
3,182 |
$34K |
| 82042 |
|
17,391 |
17,026 |
$34K |
| 95886 |
|
1,228 |
1,190 |
$33K |
| 99152 |
|
789 |
742 |
$33K |
| 90380 |
|
76 |
75 |
$32K |
| 94664 |
|
2,996 |
2,869 |
$32K |
| 95816 |
|
322 |
316 |
$32K |
| 86341 |
|
1,583 |
1,434 |
$32K |
| 86706 |
|
2,429 |
2,396 |
$32K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
9,148 |
8,325 |
$32K |
| 84480 |
|
2,372 |
2,287 |
$31K |
| 90656 |
|
1,655 |
1,654 |
$30K |
| 87902 |
|
729 |
703 |
$30K |
| G0444 |
Annual depression screening, 5 to 15 minutes |
45,349 |
43,096 |
$30K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
8,736 |
7,790 |
$30K |
| 87070 |
|
2,581 |
2,482 |
$30K |
| 85652 |
|
11,680 |
11,207 |
$30K |
| J9190 |
Injection, fluorouracil, 500 mg |
2,466 |
1,113 |
$29K |
| 88304 |
|
1,377 |
1,337 |
$29K |
| 87081 |
|
5,520 |
5,338 |
$29K |
| 84481 |
|
2,761 |
2,681 |
$29K |
| 90716 |
|
1,500 |
1,475 |
$29K |
| J2501 |
Injection, paricalcitol, 1 mcg |
19,934 |
1,680 |
$28K |
| 97802 |
|
874 |
834 |
$28K |
| 87210 |
|
5,781 |
5,450 |
$27K |
| 90734 |
|
1,381 |
1,371 |
$27K |
| 86735 |
|
1,271 |
1,234 |
$27K |
| 87536 |
|
661 |
629 |
$27K |
| J9217 |
Leuprolide acetate (for depot suspension), 7.5 mg |
53 |
50 |
$26K |
| 82105 |
|
3,904 |
3,778 |
$26K |
| 84311 |
|
2,807 |
2,654 |
$26K |
| J7298 |
Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg |
50 |
49 |
$26K |
| 88312 |
|
1,656 |
1,592 |
$26K |
| 84145 |
|
1,307 |
1,259 |
$26K |
| 94660 |
|
584 |
539 |
$25K |
| Q9956 |
Injection, octafluoropropane microspheres, per ml |
378 |
351 |
$25K |
| 99217 |
|
971 |
957 |
$25K |
| 82248 |
|
5,000 |
4,818 |
$25K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
850 |
838 |
$25K |
| 90723 |
|
2,427 |
2,395 |
$25K |
| J2704 |
Injection, propofol, 10 mg |
6,599 |
6,362 |
$25K |
| 84550 |
|
6,751 |
6,168 |
$25K |
| 97597 |
|
747 |
607 |
$25K |
| 94799 |
|
233 |
216 |
$25K |
| 87075 |
|
2,300 |
2,205 |
$24K |
| 94375 |
|
1,174 |
1,144 |
$24K |
| 72070 |
|
865 |
851 |
$24K |
| 91200 |
|
1,202 |
1,181 |
$24K |
| 90697 |
|
575 |
571 |
$24K |
| 71101 |
|
627 |
370 |
$24K |
| 73000 |
|
1,332 |
1,205 |
$24K |
| 90649 |
|
243 |
240 |
$23K |
| 93288 |
|
934 |
904 |
$23K |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
813 |
733 |
$23K |
| 73521 |
|
992 |
964 |
$23K |
| 85007 |
|
6,910 |
5,998 |
$23K |
| 88342 |
|
267 |
261 |
$22K |
| 92134 |
|
2,016 |
1,939 |
$22K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
9,652 |
8,807 |
$22K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
4,476 |
3,850 |
$22K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
15,004 |
12,888 |
$21K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
5,336 |
5,010 |
$21K |
| 87338 |
|
3,809 |
3,726 |
$20K |
| 73140 |
|
1,489 |
1,381 |
$20K |
| J8540 |
Dexamethasone, oral, 0.25 mg |
12,525 |
7,228 |
$20K |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
1,816 |
1,656 |
$20K |
| 99224 |
|
346 |
338 |
$20K |
| 58100 |
|
849 |
822 |
$20K |
| 82553 |
|
898 |
794 |
$19K |
| 95909 |
|
324 |
322 |
$19K |
| 97803 |
|
1,039 |
1,025 |
$19K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,077 |
1,016 |
$18K |
| 10060 |
|
1,096 |
1,052 |
$18K |
| 90633 |
|
2,067 |
2,050 |
$18K |
| 84520 |
|
6,523 |
5,964 |
$17K |
| 86235 |
|
969 |
899 |
$17K |
| 94760 |
|
3,331 |
3,072 |
$17K |
| 82040 |
|
4,569 |
4,291 |
$17K |
| 83516 |
|
2,323 |
2,273 |
$16K |
| 0983 |
|
1,759 |
1,709 |
$16K |
| 11721 |
|
2,676 |
2,630 |
$16K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
4,744 |
4,444 |
$16K |
| 73718 |
|
61 |
60 |
$16K |
| 90658 |
|
1,488 |
1,463 |
$16K |
| 90647 |
|
1,929 |
1,910 |
$16K |
| 94010 |
|
297 |
272 |
$16K |
| J7050 |
Infusion, normal saline solution, 250 cc |
21,234 |
14,342 |
$16K |
| 82533 |
|
986 |
919 |
$16K |
| 86431 |
|
3,761 |
3,628 |
$16K |
| 49083 |
|
451 |
234 |
$16K |
| 82951 |
|
1,981 |
1,948 |
$15K |
| 80069 |
|
2,867 |
2,774 |
$15K |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
1,933 |
1,665 |
$15K |
| 90381 |
|
30 |
29 |
$15K |
| 0270 |
|
2,905 |
2,163 |
$15K |
| 29581 |
|
425 |
327 |
$15K |
| 86580 |
|
3,468 |
3,019 |
$15K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
457 |
438 |
$15K |
| 86304 |
|
1,793 |
1,663 |
$15K |
| 82261 |
|
1,012 |
1,009 |
$14K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
5,514 |
3,061 |
$14K |
| 86787 |
|
1,659 |
1,563 |
$14K |
| 72128 |
|
100 |
100 |
$14K |
| 88141 |
|
3,579 |
3,510 |
$14K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
830 |
660 |
$14K |
| 74170 |
|
72 |
68 |
$14K |
| 12001 |
|
946 |
924 |
$14K |
| J9263 |
Injection, oxaliplatin, 0.5 mg |
1,260 |
359 |
$14K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
221 |
221 |
$14K |
| 72082 |
|
374 |
367 |
$14K |
| S0077 |
Injection, clindamycin phosphate, 300 mg |
1,258 |
1,167 |
$14K |
| 84402 |
|
1,088 |
1,064 |
$13K |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
1,817 |
1,734 |
$13K |
| 82565 |
|
4,625 |
4,391 |
$13K |
| 84134 |
|
1,145 |
980 |
$13K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
703 |
667 |
$13K |
| 90632 |
|
309 |
304 |
$13K |
| 90654 |
|
706 |
702 |
$13K |
| 99404 |
|
165 |
150 |
$13K |
| J1250 |
Injection, dobutamine hydrochloride, per 250 mg |
935 |
894 |
$13K |
| Q9957 |
Injection, perflutren lipid microspheres, per ml |
167 |
157 |
$13K |
| 86592 |
|
3,302 |
3,168 |
$12K |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
252 |
191 |
$12K |
| 83020 |
|
927 |
918 |
$12K |
| Q0144 |
Azithromycin dihydrate, oral, capsules/powder, 1 gram |
1,234 |
1,157 |
$12K |
| C1874 |
Stent, coated/covered, with delivery system |
12 |
12 |
$12K |
| 93283 |
|
248 |
231 |
$12K |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
6,358 |
3,272 |
$12K |
| 84403 |
|
3,154 |
3,080 |
$12K |
| 0512 |
|
467 |
374 |
$12K |
| 87205 |
|
2,116 |
2,019 |
$12K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
149 |
148 |
$12K |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
741 |
570 |
$11K |
| 86255 |
|
1,596 |
1,560 |
$11K |
| 99225 |
|
192 |
189 |
$11K |
| 84140 |
|
388 |
366 |
$11K |
| 92700 |
|
68 |
61 |
$11K |
| 86360 |
|
293 |
288 |
$11K |
| 71020 |
|
427 |
320 |
$10K |
| J1750 |
Injection, iron dextran, 50 mg |
95 |
47 |
$10K |
| 80179 |
|
717 |
689 |
$10K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
14,786 |
13,412 |
$10K |
| 86160 |
|
1,286 |
1,236 |
$10K |
| 85014 |
|
6,221 |
5,533 |
$10K |
| 90681 |
|
1,076 |
1,075 |
$10K |
| 76882 |
|
970 |
938 |
$10K |
| 77003 |
|
292 |
265 |
$9K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
79 |
79 |
$9K |
| G0008 |
Administration of influenza virus vaccine |
1,577 |
1,576 |
$9K |
| 86593 |
|
1,857 |
1,778 |
$9K |
| 94750 |
|
486 |
467 |
$9K |
| 82140 |
|
496 |
472 |
$9K |
| 84156 |
|
5,154 |
4,667 |
$9K |
| 80051 |
|
2,416 |
2,314 |
$9K |
| 82985 |
|
731 |
724 |
$9K |
| 93454 |
|
13 |
13 |
$9K |
| 82962 |
|
2,736 |
2,599 |
$9K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
160 |
158 |
$9K |
| 99153 |
Mod sedat endo service >5yrs |
525 |
490 |
$8K |
| 82784 |
|
1,484 |
1,403 |
$8K |
| G0009 |
Administration of pneumococcal vaccine |
1,259 |
1,256 |
$8K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
1,026 |
511 |
$8K |
| 12002 |
|
568 |
549 |
$8K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
171 |
170 |
$8K |
| 74220 |
|
224 |
220 |
$8K |
| J3370 |
Injection, vancomycin hcl, 500 mg |
1,060 |
910 |
$8K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
6,861 |
6,536 |
$8K |
| 99000 |
|
2,025 |
1,958 |
$8K |
| 88341 |
|
99 |
98 |
$8K |
| 96411 |
|
400 |
300 |
$8K |
| 0517 |
|
45,543 |
42,732 |
$8K |
| 77295 |
|
12 |
12 |
$8K |
| 76519 |
|
175 |
159 |
$8K |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
3,926 |
3,798 |
$8K |
| 86039 |
|
1,266 |
1,216 |
$8K |
| 90700 |
|
939 |
935 |
$8K |
| 80164 |
|
674 |
616 |
$8K |
| J1815 |
Injection, insulin, per 5 units |
1,815 |
1,036 |
$7K |
| 85045 |
|
2,939 |
2,846 |
$7K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
2,812 |
1,811 |
$7K |
| 87147 |
|
1,837 |
1,706 |
$7K |
| 86225 |
|
891 |
859 |
$7K |
| 29700 |
|
683 |
630 |
$7K |
| 94727 |
|
278 |
275 |
$7K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
16,241 |
15,370 |
$7K |
| 84681 |
|
1,412 |
1,390 |
$7K |
| G8433 |
Screening for depression not completed, documented patient or medical reason |
5,048 |
4,720 |
$7K |
| 11750 |
|
180 |
171 |
$6K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
614 |
437 |
$6K |
| 86200 |
|
2,658 |
2,583 |
$6K |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
4,666 |
4,185 |
$6K |
| 74183 |
|
25 |
24 |
$6K |
| 90648 |
|
623 |
610 |
$6K |
| 77334 |
|
26 |
25 |
$6K |
| 36600 |
|
987 |
803 |
$6K |
| 90791 |
Psychiatric diagnostic evaluation |
164 |
161 |
$6K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
4,562 |
2,815 |
$6K |
| 96402 |
|
600 |
561 |
$6K |
| 29125 |
|
986 |
926 |
$6K |
| 12011 |
|
275 |
269 |
$6K |
| 95819 |
|
158 |
157 |
$6K |
| 87088 |
|
1,132 |
1,039 |
$6K |
| 82947 |
|
3,118 |
2,945 |
$6K |
| 84436 |
|
618 |
589 |
$6K |
| 90832 |
Psychotherapy, 30 minutes with patient |
737 |
540 |
$5K |
| 73200 |
|
26 |
24 |
$5K |
| 81596 |
|
238 |
235 |
$5K |
| 85651 |
|
2,379 |
2,156 |
$5K |
| 84445 |
|
223 |
221 |
$5K |
| 77417 |
|
85 |
39 |
$5K |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
434 |
405 |
$5K |
| 82670 |
|
731 |
722 |
$5K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
752 |
643 |
$5K |
| 95912 |
|
51 |
51 |
$5K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
3,495 |
3,265 |
$5K |
| 86317 |
|
1,655 |
1,586 |
$5K |
| 86376 |
|
1,601 |
1,562 |
$5K |
| 29075 |
|
1,155 |
1,061 |
$5K |
| L0140 |
Cervical, semi-rigid, adjustable (plastic collar) |
87 |
86 |
$5K |
| 86300 |
|
860 |
743 |
$5K |
| 70360 |
|
316 |
300 |
$5K |
| 90696 |
|
534 |
533 |
$4K |
| 69210 |
|
875 |
832 |
$4K |
| 74022 |
|
106 |
96 |
$4K |
| 72220 |
|
187 |
185 |
$4K |
| 86765 |
|
1,303 |
1,276 |
$4K |
| 96409 |
|
249 |
121 |
$4K |
| 86800 |
|
780 |
726 |
$4K |
| 86256 |
|
404 |
401 |
$4K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
3,613 |
2,790 |
$4K |
| 93282 |
|
99 |
97 |
$4K |
| 64635 |
|
39 |
28 |
$4K |
| J2916 |
Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg |
320 |
164 |
$4K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
6,746 |
6,260 |
$4K |
| 82247 |
|
862 |
689 |
$4K |
| 95885 |
|
141 |
141 |
$4K |
| 72083 |
|
84 |
84 |
$4K |
| 76706 |
|
88 |
88 |
$4K |
| 72197 |
|
13 |
12 |
$4K |
| 57454 |
|
169 |
163 |
$3K |
| 90680 |
|
404 |
399 |
$3K |
| G0202 |
Screening mammography, bilateral (2-view study of each breast), including computer-aided detection (cad) when performed |
44 |
43 |
$3K |
| 52000 |
|
57 |
55 |
$3K |
| 84154 |
|
662 |
649 |
$3K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
318 |
305 |
$3K |
| 70320 |
|
98 |
87 |
$3K |
| 83520 |
|
269 |
264 |
$3K |
| J0694 |
Injection, cefoxitin sodium, 1 gm |
350 |
305 |
$3K |
| 82375 |
|
266 |
251 |
$3K |
| 86677 |
|
149 |
144 |
$3K |
| 82310 |
|
971 |
929 |
$3K |
| 86696 |
|
496 |
433 |
$3K |
| 62323 |
|
70 |
70 |
$3K |
| J2060 |
Injection, lorazepam, 2 mg |
2,270 |
1,999 |
$3K |
| S0164 |
Injection, pantoprazole sodium, 40 mg |
290 |
208 |
$3K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
1,323 |
761 |
$3K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
380 |
373 |
$3K |
| 86709 |
|
151 |
150 |
$3K |
| 82150 |
|
506 |
463 |
$3K |
| 51702 |
|
352 |
318 |
$3K |
| 84300 |
|
600 |
580 |
$3K |
| 87517 |
|
100 |
98 |
$3K |
| 69209 |
|
497 |
456 |
$3K |
| 83935 |
|
416 |
398 |
$3K |
| A9541 |
Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries |
12 |
12 |
$3K |
| 97162 |
|
128 |
128 |
$3K |
| 84165 |
|
389 |
364 |
$3K |
| 87641 |
|
123 |
114 |
$3K |
| 86708 |
|
186 |
183 |
$3K |
| L3929 |
Hand finger orthosis, includes one or more nontorsion joint(s), turnbuckles, elastic bands/springs, may include soft interface material, straps, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise |
39 |
38 |
$3K |
| 99199 |
Unlisted special service, procedure or report |
56 |
47 |
$3K |
| J2785 |
Injection, regadenoson, 0.1 mg |
90 |
87 |
$3K |
| 84425 |
|
209 |
207 |
$3K |
| 58300 |
|
378 |
368 |
$3K |
| 73020 |
|
110 |
101 |
$3K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
24 |
24 |
$2K |
| 82652 |
|
839 |
704 |
$2K |
| 72080 |
|
90 |
88 |
$2K |
| Z7514 |
|
41 |
38 |
$2K |
| 86695 |
|
524 |
432 |
$2K |
| 29085 |
|
357 |
337 |
$2K |
| 76516 |
|
67 |
60 |
$2K |
| 82088 |
|
249 |
245 |
$2K |
| 43235 |
|
74 |
74 |
$2K |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
508 |
490 |
$2K |
| 90733 |
|
29 |
29 |
$2K |
| 93975 |
|
14 |
14 |
$2K |
| 93923 |
|
25 |
24 |
$2K |
| 83930 |
|
287 |
280 |
$2K |
| 11055 |
|
828 |
758 |
$2K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
233 |
221 |
$2K |
| 45382 |
|
37 |
37 |
$2K |
| 87901 |
|
126 |
109 |
$2K |
| 20550 |
|
201 |
195 |
$2K |
| 83090 |
|
429 |
424 |
$2K |
| 90682 |
|
66 |
66 |
$2K |
| 74240 |
|
40 |
40 |
$2K |
| 90685 |
|
202 |
200 |
$2K |
| 36592 |
|
85 |
50 |
$2K |
| 36430 |
|
73 |
51 |
$2K |
| 88173 |
|
174 |
166 |
$2K |
| 83050 |
|
266 |
251 |
$2K |
| 86704 |
|
514 |
497 |
$2K |
| J0461 |
Injection, atropine sulfate, 0.01 mg |
623 |
467 |
$2K |
| 99385 |
|
16 |
16 |
$2K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
37 |
37 |
$2K |
| 10005 |
|
58 |
55 |
$2K |
| 76820 |
|
104 |
52 |
$2K |
| 90620 |
|
131 |
131 |
$2K |
| 29515 |
|
253 |
236 |
$2K |
| 84270 |
|
133 |
133 |
$2K |
| 94618 |
|
64 |
64 |
$2K |
| 83655 |
|
159 |
154 |
$2K |
| 51798 |
|
194 |
190 |
$2K |
| 86146 |
|
55 |
53 |
$2K |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
2,208 |
1,855 |
$2K |
| 92250 |
|
115 |
110 |
$2K |
| 82950 |
|
1,064 |
1,007 |
$2K |
| J9171 |
Injection, docetaxel, 1 mg |
25 |
12 |
$2K |
| 87045 |
|
214 |
207 |
$2K |
| J0735 |
Injection, clonidine hydrochloride, 1 mg |
189 |
162 |
$2K |
| 78306 |
|
12 |
12 |
$1K |
| Q0163 |
Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen |
3,776 |
2,600 |
$1K |
| 93289 |
|
36 |
32 |
$1K |
| 93280 |
|
145 |
141 |
$1K |
| 86015 |
|
332 |
324 |
$1K |
| 29065 |
|
422 |
386 |
$1K |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
517 |
506 |
$1K |
| 82785 |
|
488 |
476 |
$1K |
| 91320 |
|
30 |
29 |
$1K |
| J9045 |
Injection, carboplatin, 50 mg |
71 |
38 |
$1K |
| 88112 |
|
98 |
88 |
$1K |
| 29405 |
|
155 |
136 |
$1K |
| 76942 |
|
26 |
25 |
$1K |
| J9267 |
Injection, paclitaxel, 1 mg |
72 |
25 |
$1K |
| 86769 |
|
32 |
30 |
$1K |
| 82024 |
|
284 |
267 |
$1K |
| G9578 |
Documentation of signed opioid treatment agreement at least once during opioid therapy |
1,291 |
1,144 |
$1K |
| 77290 |
|
12 |
12 |
$1K |
| 86702 |
|
110 |
104 |
$1K |
| 84244 |
|
239 |
238 |
$1K |
| 64636 |
|
25 |
16 |
$1K |
| G0010 |
Administration of hepatitis b vaccine |
103 |
102 |
$1K |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
116 |
102 |
$1K |
| 76001 |
|
16 |
13 |
$1K |
| J1940 |
Injection, furosemide, up to 20 mg |
695 |
491 |
$1K |
| J7999 |
Compounded drug, not otherwise classified |
79 |
70 |
$1K |
| 71010 |
|
85 |
78 |
$1K |
| 99383 |
|
14 |
14 |
$1K |
| 86334 |
|
72 |
66 |
$1K |
| 86701 |
|
110 |
104 |
$1K |
| 82977 |
|
128 |
125 |
$1K |
| 90739 |
|
14 |
13 |
$1K |
| 11720 |
|
339 |
332 |
$1K |
| 93041 |
|
92 |
37 |
$1K |
| 84133 |
|
196 |
191 |
$1K |
| 86361 |
|
95 |
92 |
$1K |
| 90713 |
|
114 |
114 |
$1K |
| 84155 |
|
347 |
329 |
$1K |
| A9581 |
Injection, gadoxetate disodium, 1 ml |
92 |
90 |
$1K |
| 99382 |
|
15 |
15 |
$1K |
| 82627 |
|
302 |
299 |
$1K |
| 76775 |
|
14 |
14 |
$975.39 |
| 93284 |
|
19 |
17 |
$968.42 |
| 84478 |
|
256 |
214 |
$950.09 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
248 |
141 |
$936.94 |
| 98926 |
|
50 |
45 |
$935.03 |
| L3763 |
Elbow wrist hand orthosis, rigid, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment |
27 |
25 |
$909.12 |
| 85732 |
|
161 |
159 |
$868.01 |
| 83883 |
|
29 |
26 |
$864.83 |
| G0500 |
Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) |
18 |
18 |
$807.75 |
| 90834 |
Psychotherapy, 45 minutes with patient |
312 |
231 |
$805.92 |
| 90619 |
|
43 |
43 |
$797.66 |
| 29105 |
|
112 |
105 |
$790.47 |
| 66821 |
|
28 |
26 |
$778.55 |
| 95910 |
|
12 |
12 |
$760.50 |
| 11200 |
|
97 |
95 |
$753.60 |
| 87625 |
|
55 |
55 |
$744.84 |
| 70355 |
|
31 |
26 |
$733.44 |
| J1630 |
Injection, haloperidol, up to 5 mg |
480 |
444 |
$728.20 |
| 93042 |
|
39 |
34 |
$725.21 |
| 96368 |
|
37 |
27 |
$718.50 |
| 84207 |
|
93 |
93 |
$711.52 |
| 87046 |
|
215 |
208 |
$706.03 |
| 92081 |
|
16 |
16 |
$693.68 |
| 76512 |
|
13 |
13 |
$691.79 |
| 95907 |
|
19 |
19 |
$661.64 |
| G8484 |
Influenza immunization was not administered, reason not given |
2,826 |
2,668 |
$656.20 |
| 74420 |
|
14 |
14 |
$656.06 |
| 83521 |
|
27 |
25 |
$653.62 |
| 90744 |
|
68 |
68 |
$652.96 |
| 11056 |
|
397 |
384 |
$644.96 |
| 83021 |
|
107 |
106 |
$592.72 |
| J1953 |
Injection, levetiracetam, 10 mg |
141 |
66 |
$569.53 |
| 82103 |
|
175 |
170 |
$566.57 |
| 86705 |
|
53 |
53 |
$564.96 |
| 86021 |
|
47 |
43 |
$555.06 |
| 29705 |
|
164 |
152 |
$517.92 |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
38 |
37 |
$475.62 |
| 0250 |
|
1,252 |
698 |
$464.77 |
| 83835 |
|
49 |
45 |
$460.40 |
| 16020 |
|
58 |
57 |
$432.70 |
| 3080F |
|
28,551 |
26,580 |
$428.12 |
| 20605 |
|
16 |
15 |
$422.23 |
| 84432 |
|
70 |
68 |
$421.06 |
| 92136 |
|
13 |
13 |
$417.41 |
| 89051 |
|
41 |
38 |
$416.15 |
| 86147 |
|
69 |
53 |
$410.42 |
| 85041 |
|
276 |
274 |
$410.17 |
| 82465 |
|
149 |
143 |
$407.72 |
| J0290 |
Injection, ampicillin sodium, 500 mg |
161 |
123 |
$392.47 |
| J1626 |
Injection, granisetron hydrochloride, 100 mcg |
165 |
161 |
$377.30 |
| 70300 |
|
56 |
50 |
$371.51 |
| 82436 |
|
56 |
54 |
$370.42 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
77 |
64 |
$343.70 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
208 |
203 |
$340.51 |
| Z7512 |
|
13 |
13 |
$339.69 |
| J0456 |
Injection, azithromycin, 500 mg |
124 |
117 |
$339.66 |
| 96160 |
|
431 |
431 |
$336.99 |
| 86301 |
|
55 |
49 |
$296.89 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
179 |
177 |
$283.08 |
| J0571 |
Buprenorphine, oral, 1 mg |
25 |
15 |
$279.46 |
| 82542 |
|
13 |
12 |
$275.56 |
| 20553 |
|
13 |
13 |
$255.03 |
| 97161 |
|
12 |
12 |
$252.48 |
| 84255 |
|
12 |
12 |
$248.50 |
| 31575 |
|
13 |
13 |
$240.00 |
| J3360 |
Injection, diazepam, up to 5 mg |
72 |
68 |
$234.43 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
182 |
178 |
$220.49 |
| 1036F |
|
269,270 |
216,070 |
$216.64 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
20 |
20 |
$213.06 |
| A9503 |
Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries |
16 |
16 |
$207.48 |
| 82270 |
|
282 |
278 |
$189.34 |
| 92551 |
|
12 |
12 |
$175.56 |
| G9579 |
No documentation of signed an opioid treatment agreement at least once during opioid therapy |
100 |
85 |
$173.25 |
| 80178 |
|
93 |
68 |
$170.66 |
| 84144 |
|
42 |
41 |
$168.00 |
| 85460 |
|
13 |
12 |
$156.47 |
| J7042 |
5% dextrose/normal saline (500 ml = 1 unit) |
81 |
56 |
$156.40 |
| 3061F |
|
13,247 |
10,852 |
$154.43 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
616 |
557 |
$149.16 |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
133 |
132 |
$146.59 |
| 88302 |
|
25 |
24 |
$145.26 |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
19 |
14 |
$145.09 |
| 85008 |
|
38 |
37 |
$144.62 |
| 83498 |
|
26 |
26 |
$144.30 |
| J0295 |
Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm |
25 |
24 |
$136.36 |
| 3074F |
|
189,309 |
163,927 |
$136.34 |
| 82672 |
|
26 |
25 |
$133.80 |
| 11981 |
|
12 |
12 |
$126.00 |
| 11730 |
|
12 |
12 |
$126.00 |
| 82390 |
|
114 |
111 |
$122.08 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
698 |
625 |
$119.49 |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
214 |
208 |
$118.83 |
| 3052F |
|
10,577 |
8,676 |
$116.47 |
| 80197 |
|
14 |
13 |
$113.23 |
| 83525 |
|
12 |
12 |
$112.55 |
| 84466 |
|
26 |
26 |
$112.12 |
| 83993 |
|
14 |
14 |
$109.92 |
| 3077F |
|
62,494 |
55,813 |
$105.45 |
| 58301 |
|
14 |
13 |
$97.52 |
| J1020 |
Injection, methylprednisolone acetate, 20 mg |
15 |
13 |
$96.95 |
| 87177 |
|
16 |
15 |
$87.00 |
| 87209 |
|
16 |
15 |
$87.00 |
| 84450 |
|
13 |
13 |
$86.31 |
| 84540 |
|
13 |
12 |
$85.20 |
| 86812 |
|
13 |
12 |
$82.20 |
| 87400 |
|
13 |
13 |
$75.27 |
| 17340 |
|
25 |
25 |
$75.00 |
| 84630 |
|
26 |
26 |
$73.92 |
| J1580 |
Injection, garamycin, gentamicin, up to 80 mg |
13 |
12 |
$68.77 |
| C9257 |
Injection, bevacizumab, 0.25 mg |
13 |
13 |
$67.19 |
| 84590 |
|
14 |
14 |
$62.92 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
124 |
92 |
$60.30 |
| 3078F |
|
181,420 |
156,401 |
$42.94 |
| 3048F |
|
34,364 |
28,762 |
$42.94 |
| J1790 |
Injection, droperidol, up to 5 mg |
41 |
39 |
$37.60 |
| J3480 |
Injection, potassium chloride, per 2 meq |
29 |
13 |
$34.72 |
| 3075F |
|
55,410 |
52,158 |
$33.03 |
| 90480 |
|
15 |
14 |
$31.46 |
| 83986 |
|
104 |
101 |
$26.10 |
| 89055 |
|
14 |
14 |
$23.87 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
13 |
12 |
$23.28 |
| 4004F |
|
10,110 |
9,746 |
$22.45 |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
138 |
135 |
$20.76 |
| 83519 |
|
16 |
12 |
$14.94 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
370 |
359 |
$13.21 |
| 3044F |
|
109,258 |
94,801 |
$12.93 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
1,775 |
1,601 |
$10.00 |
| G8483 |
Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) |
1,013 |
818 |
$5.00 |
| 90378 |
|
13 |
13 |
$3.25 |
| 3046F |
|
16,553 |
13,754 |
$0.00 |
| G8482 |
Influenza immunization administered or previously received |
424 |
413 |
$0.00 |
| 3050F |
|
18,365 |
16,167 |
$0.00 |
| 3051F |
|
15,108 |
12,163 |
$0.00 |
| G0476 |
Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test |
455 |
455 |
$0.00 |
| 80321 |
|
75 |
63 |
$0.00 |
| 3045F |
|
263 |
259 |
$0.00 |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
27 |
27 |
$0.00 |
| G8511 |
Screening for depression documented as positive, follow-up plan not documented, reason not given |
1,468 |
1,428 |
$0.00 |
| 3062F |
|
445 |
309 |
$0.00 |
| 90837 |
Psychotherapy, 53 minutes with patient |
51 |
40 |
$0.00 |
| 0272 |
|
13 |
12 |
$0.00 |
| 2028F |
|
25 |
24 |
$0.00 |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
12 |
12 |
$0.00 |
| 80361 |
|
13 |
13 |
$0.00 |
| 0031A |
|
34 |
34 |
$0.00 |
| 3060F |
|
6,875 |
5,530 |
$0.00 |
| 3079F |
|
91,774 |
83,785 |
$0.00 |
| H0049 |
Alcohol and/or drug screening |
345 |
342 |
$0.00 |
| 3351F |
|
179 |
168 |
$0.00 |
| H0001 |
Alcohol and/or drug assessment |
1,387 |
1,386 |
$0.00 |
| 80363 |
|
95 |
94 |
$0.00 |
| G9012 |
Other specified case management service not elsewhere classified |
19 |
14 |
$0.00 |
| Q4051 |
Splint supplies, miscellaneous (includes thermoplastics, strapping, fasteners, padding and other supplies) |
16 |
13 |
$0.00 |
| 81599 |
|
13 |
13 |
$0.00 |